165.04
price up icon2.38%   3.843
after-market After Hours: 164.87 -0.1723 -0.10%
loading
Tradr 2 X Long Innovation 100 Quarterly Etf stock is traded at $165.04, with a volume of 448. It is up +2.38% in the last 24 hours and down -0.93% over the past month.
See More
Previous Close:
$161.20
Open:
$165.43
24h Volume:
448
Relative Volume:
0.22
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-2.65%
1M Performance:
-0.93%
6M Performance:
-0.27%
1Y Performance:
+42.17%
1-Day Range:
Value
$164.87
$165.43
1-Week Range:
Value
$160.59
$169.85
52-Week Range:
Value
$82.50
$190.01

Tradr 2 X Long Innovation 100 Quarterly Etf Stock (QQQP) Company Profile

Name
Name
Tradr 2 X Long Innovation 100 Quarterly Etf
Name
Phone
-
Name
Address
-
Name
Employee
0
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
QQQP's Discussions on Twitter

Compare QQQP vs VTI, SPY, IVV, VB, QQQ

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Exchange Traded Fund icon
QQQP
Tradr 2 X Long Innovation 100 Quarterly Etf
165.04 0 0 0 0 0.00
Exchange Traded Fund icon
VTI
Vanguard Total Stock Market Etf
329.46 417.53B 0 0 0 0.00
Exchange Traded Fund icon
SPY
State Street Spdr S P 500 Etf Trust
669.03 372.57B 0 0 0 0.00
Exchange Traded Fund icon
IVV
Ishares Core S P 500 Etf
671.91 253.41B 0 0 0 0.00
Exchange Traded Fund icon
VB
Vanguard Small Cap Etf
262.88 160.59B 0 0 0 0.00
Exchange Traded Fund icon
QQQ
Invesco Qqq Trust Series 1
600.38 124.43B 0 0 0 0.00

Tradr 2 X Long Innovation 100 Quarterly Etf Stock (QQQP) Latest News

pulisher
Mar 03, 2026

Osteoarthritis Clinical Trial Pipeline Expands as 100+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart.com

Mar 03, 2026
pulisher
Mar 02, 2026

Multiple Myeloma Clinical Trial Pipeline Expands as 75+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart.com

Mar 02, 2026
pulisher
Feb 26, 2026

Vonage Brings Network Innovation to Mobile World Congress 2026 - Barchart.com

Feb 26, 2026
pulisher
Feb 26, 2026

Stock List: Research Stocks from Around the World - GuruFocus

Feb 26, 2026
pulisher
Feb 24, 2026

Hepatic Tumor Clinical Trial Pipeline Expands as 75+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart.com

Feb 24, 2026
pulisher
Feb 24, 2026

Danaher Announces Quarterly Dividend - Barchart.com

Feb 24, 2026
pulisher
Feb 24, 2026

QQQP Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Feb 24, 2026
pulisher
Feb 24, 2026

QQQP Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Feb 24, 2026
pulisher
Feb 24, 2026

Western Digital Is Selling Sandisk Stock. Should You? - Barchart.com

Feb 24, 2026
pulisher
Feb 19, 2026

1 Nasdaq 100 Stock for Long-Term Investors and 2 That Underwhelm - Barchart.com

Feb 19, 2026
pulisher
Feb 19, 2026

DuPont Announces Regular Quarterly Dividend on Common Stock - Barchart.com

Feb 19, 2026
pulisher
Feb 19, 2026

Amkor Technology Declares Quarterly Dividend - Barchart.com

Feb 19, 2026
pulisher
Feb 19, 2026

Workiva’s (NYSE:WK) Q4 CY2025 Sales Beat Estimates, Stock Soars - Barchart.com

Feb 19, 2026
pulisher
Feb 19, 2026

AbbVie Declares Quarterly Dividend - Barchart.com

Feb 19, 2026
pulisher
Feb 19, 2026

Ocular melanoma Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Delcath System, Aura Biosciences, Seagen, IDEAYA, Ascentage Pharma - Barchart.com

Feb 19, 2026
pulisher
Feb 19, 2026

Evogene Schedules Fourth Quarter and Full Year 2025 Financial Results Release - Barchart.com

Feb 19, 2026
pulisher
Feb 19, 2026

Humana Board Declares Payment of Quarterly Dividend to Stockholders - Barchart.com

Feb 19, 2026
pulisher
Feb 18, 2026

Eczema Pipeline 2026 Outlook: 100+ Clinical Assets and 3 Key Late-Stage Candidates to Watch, analyses DelveInsight - Barchart.com

Feb 18, 2026
pulisher
Feb 18, 2026

Matthew Chapman – Windermere Real Estate Named #1 Real Estate Agent in Bellevue by CX Research Institute - Barchart.com

Feb 18, 2026
pulisher
Feb 18, 2026

Coherent Corp. to Host a Technology Innovation Briefing on March 17, 2026 - Barchart.com

Feb 18, 2026
pulisher
Feb 18, 2026

CAMTEK ANNOUNCES RECORD RESULTS FOR THE FOURTH QUARTER & FULL YEAR 2025 - Barchart.com

Feb 18, 2026
pulisher
Feb 17, 2026

Hormel Foods Announces Preliminary First Quarter 2026 Results and Reaffirms Full-Year Adjusted Guidance - Barchart.com

Feb 17, 2026
pulisher
Feb 17, 2026

Cathie Wood Adds 210K Shares to a Rising AI Bet With Upside of 102% - Barchart.com

Feb 17, 2026
pulisher
Feb 17, 2026

West Announces Quarterly Dividend and Share Repurchase Program - Barchart.com

Feb 17, 2026
pulisher
Feb 17, 2026

Webull to Release Fourth Quarter 2025 Results on March 4, 2026 - Barchart.com

Feb 17, 2026
pulisher
Feb 13, 2026

Symbol Lookup - GuruFocus

Feb 13, 2026
pulisher
Feb 13, 2026

Enpro Increases Quarterly Dividend - Barchart.com

Feb 13, 2026
pulisher
Feb 13, 2026

ABNB Q4 Deep Dive: Product Innovation and Global Expansion Drive Momentum - Barchart.com

Feb 13, 2026
pulisher
Feb 12, 2026

SPY, QQQP: Big ETF Outflows - Intellectia AI

Feb 12, 2026
pulisher
Feb 12, 2026

Stocks Rise Before the Open on U.S. Economic Optimism, Earnings and Jobless Claims Data in Focus - Barchart.com

Feb 12, 2026
pulisher
Feb 12, 2026

CarParts.com Sets Fourth Quarter 2025 Conference Call for Thursday, March 5, 2026 - Barchart.com

Feb 12, 2026
pulisher
Feb 11, 2026

V2X Awarded $100M In National Security Contracts - Barchart.com

Feb 11, 2026
pulisher
Feb 11, 2026

Radian Declares Regular Quarterly Dividend - Barchart.com

Feb 11, 2026
pulisher
Feb 10, 2026

Coca-Cola demand rises in fourth quarter but shares slide on tepid outlook - Barchart.com

Feb 10, 2026
pulisher
Feb 09, 2026

Ichthyosis Market: Rapid Increment Driven by Innovation – DelveInsight | Timber Pharma, Krystal Biotech, GSK, Timber Pharma, Janssen Scientific - Barchart.com

Feb 09, 2026
pulisher
Feb 07, 2026

IgA Nephropathy Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Visterra, Chinook Therapeutics, Novartis, IgA proteases Selecta Biosciences - Barchart.com

Feb 07, 2026
pulisher
Feb 05, 2026

Bladder Cancer Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Bristol-Myers Squibb Company, GlaxoSmithKline PLC., Johnson & Johnson, Janssen Pharma, F. Hoffmann-La Roche., Merck - Barchart.com

Feb 05, 2026
pulisher
Feb 05, 2026

Vonage Wins Two Juniper Research Awards for Innovation in Network and Mobile Identity Solutions - Barchart.com

Feb 05, 2026
pulisher
Feb 05, 2026

Advanced Energy Declares Quarterly Cash Dividend - Barchart.com

Feb 05, 2026
pulisher
Feb 05, 2026

Diabetes Clinical Trial Pipeline Expands as 200+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart.com

Feb 05, 2026
pulisher
Feb 04, 2026

Salesforce Announces Timing of its Fourth Quarter and Full Year Fiscal 2026 Results Conference Call - Barchart.com

Feb 04, 2026
pulisher
Feb 04, 2026

Epique Realty Named 2026 HousingWire Tech100 Real Estate Winner - Barchart.com

Feb 04, 2026
pulisher
Feb 04, 2026

CMG Q4 Deep Dive: Value Push, Menu Innovation, and Margins Under Pressure - Barchart.com

Feb 04, 2026
pulisher
Feb 03, 2026

Franklin Resources, Inc. Announces Quarterly Dividend - Barchart.com

Feb 03, 2026
pulisher
Feb 03, 2026

Cathie Wood Keeps Buying Joby Aviation Stock. Should You? - Barchart.com

Feb 03, 2026
pulisher
Feb 02, 2026

7 Best Tech ETFs to Buy in 2026 | Investing - US News Money

Feb 02, 2026
pulisher
Jan 31, 2026

Playground Play Equipment Innovation Sets New Benchmark for Safe, Engaging Spaces, Says Golden Times - Barchart.com

Jan 31, 2026
pulisher
Jan 31, 2026

Starbucks feels the heat as more chains compete for US coffee drinkers - Barchart.com

Jan 31, 2026
pulisher
Jan 30, 2026

Orbit Capital Announces Founder First Ecosystem Supporting 45 Companies - Barchart.com

Jan 30, 2026
pulisher
Jan 30, 2026

Dr. Nitun Ahir Establishes New Academic Scholarship to Foster Innovation and Strategic Leadership in Modern Medicine - Barchart.com

Jan 30, 2026
pulisher
Jan 30, 2026

Dr. Robert Corkern Award for Entrepreneurs Announces 2026 Application Cycle for Undergraduate Innovators - Barchart.com

Jan 30, 2026

Tradr 2 X Long Innovation 100 Quarterly Etf Stock (QQQP) Financials Data

There is no financial data for Tradr 2 X Long Innovation 100 Quarterly Etf (QQQP). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
exchange_traded_fund VTV
$198.77
price up icon 0.76%
exchange_traded_fund VUG
$455.58
price up icon 1.19%
exchange_traded_fund IJH
$67.37
price up icon 0.70%
exchange_traded_fund EFA
$98.10
price up icon 1.87%
exchange_traded_fund IWF
$443.56
price up icon 1.20%
exchange_traded_fund QQQ
$600.38
price up icon 1.12%
Cap:     |  Volume (24h):